
Sign up to save your podcasts
Or
Failure to initiate an SGLT2i to an eligible HFrEF patient exposes the patient to higher risk of early post-discharge death and readmission, and the real risk that the medication never gets prescribed at all.
In this interview, Stephen J. Greene, MD and Christopher B. Granger MD, FACC, with Ioannis Mastoris, MD, MPH, discuss In-Hospital Initiation of Sodium Glucose Cotransporter-2 Inhibitors for Heart Failure with Reduced Ejection Fraction.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
3.7
5353 ratings
Failure to initiate an SGLT2i to an eligible HFrEF patient exposes the patient to higher risk of early post-discharge death and readmission, and the real risk that the medication never gets prescribed at all.
In this interview, Stephen J. Greene, MD and Christopher B. Granger MD, FACC, with Ioannis Mastoris, MD, MPH, discuss In-Hospital Initiation of Sodium Glucose Cotransporter-2 Inhibitors for Heart Failure with Reduced Ejection Fraction.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
131 Listeners
323 Listeners
160 Listeners
863 Listeners
496 Listeners
274 Listeners
3,318 Listeners
86 Listeners
135 Listeners
1,084 Listeners
39 Listeners
186 Listeners
351 Listeners
424 Listeners
34 Listeners